Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.20.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Operating expenses:        
General and administrative $ 1,100,719 $ 441,251 $ 2,117,290 $ 977,300
Research and development 600,769 228,401 894,896 775,718
Total operating expenses 1,701,488 669,652 3,012,186 1,753,018
NET LOSS $ (1,701,488) $ (669,652) $ (3,012,186) $ (1,753,018)
Net loss per share of common shares, basic and diluted (in Dollars per share) $ (0.27) $ (0.34) $ (0.82) $ (0.89)
Weighted-average number of common shares outstanding, basic and diluted (in Shares) 6,217,577 1,978,269 3,661,942 1,978,269